AITUF yields 1.96% · PFE yields 6.13%● Live data
📍 AITUF pulled ahead of the other in Year 1
Combined, AITUF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AITUF + PFE for your $10,000?
Anritsu Corporation develops, manufactures, and sells electronic measurement instruments and systems for various communications applications in Japan and internationally. It operates through Test and Measurement, Products Quality Assurance, and Others segments. The company's test and measurement products include bit error rate tester and sampling oscilloscope; mobile/wireless communications measuring instruments, such as base station analyzers, Bluetooth and WLAN testers, cable and antenna analyzers, channel emulators/fading simulators, conformance test systems, handset one box testers, land mobile radio products, passive intermodulation analyzers, shield boxes/chambers, and signaling testers; optical measuring instruments comprising OTDRs, optical loss test set/light source/optical power meter products, optical spectrum analyzers, video inspection probes, and accessories; RF microwave measuring instruments, such as peripheral equipment, and power meters and sensors; signal generators; and signal/spectrum analyzers, vector network analyzers, and transport and ethernet testing products. It also provides X-Ray inspection systems, checkweighers, automatic combination weighers, and metal detectors for the food, pharmaceutical, and cosmetics industries, as well as service assurance solutions; designs and produces precision microwave components; and comprehensive production management system. In addition, the company offers optical sensing for industry and healthcare sectors; optical devices for communication sector; and electron devices. Further, it engages in the environmental measurement, logistics, welfare services, real estate leasing, corporate administration, and part manufacturing and other businesses. The company was founded in 1895 and is headquartered in Atsugi, Japan.
Full AITUF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.